Prognostic factors in neuroendocrine tumours of the lung: A single-centre experience

European Journal of Cardio-thoracic Surgery

Volumn 45, Issue 3, 2014, Pages 521-526

  Filosso, Pier Luigi ^a   Ruffini, Enrico ^a   Di Gangi, Stefania ^b   Guerrera, Francesco ^a   Bora, Giulia ^a   Ciccone, Giovannino ^b   Galassi, Claudia ^b   Solidoro, Paolo ^b   Lyberis, Paraskevas ^a   Oliaro, Alberto ^a   Sandri, Alberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Carcinoid; Large cell neuroendocrine carcinoma; Lung cancer; Metastases; Neuroendocrine tumours; Small cell lung cancer; Surgery

Indexed keywords

ADULT; AGED; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LUNG NEOPLASMS; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; NEUROENDOCRINE TUMORS; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84894314604     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt442     Document Type: Article

References (22)

1. Travis WD, Brambilla E, Mueller-Hermelink HK, Harris CC. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004.
2. Travis WD. Advances in neuroendocrine lung tumors. Ann Oncol 2010;21: s65-71.
3. Righi L, Volante M, Rapa I, Scagliotti G, Papotti M. Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data. Virchows Arch 2007;451:s51-9.
4. Lim E, Goldstraw P, Nicholson AG, Travis WD, Jett J, Ferolla P et al. Proceedings of the IASLC international workshop on advances in pulmonary neuroendocrine tumors 2007. J Thorac Oncol 2008;3:1194-201.
5. Vorlotto JM, Medford-Davis LN, Recht A, Flickinger JC, Schafer E, Zander DS et al. Should large cell neuroendocrine lung carcinoma be classified and treated as a small cell lung cancer or with other large cell carcinomas?. J Thorac Oncol 2011;6:1050-8.
6. Lim E, Yap YK, De Stavola BL, Nicholson AG, Goldstraw P. The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors. J Thorac Cardiovasc Surg 2005;130:969-72.
7. Asamura H, Kameya T, Matsuno Y, Masayuki N, Tada H, Ishikawa Y et al. Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 2006;24:70-6.
8. Goldstraw P. International Association for the Study of Lung Cancer (IASLC) Staging Manual in Thoracic Oncology. Orange Park, FL, USA: Editorial Rx Press, 2009.
9. Roth P. Missing data: a conceptual review for applied psychologists. Personnel Psychol 1994;47:537-60.
10. Schnonlau M. Stata Software Package, Hotdeckvar.pkg, for Hotdeck Imputation, 2006. http://www.schonlau.net/stata
11. Volante M, Rindi G, Papotti M. The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumors: a comment on concepts and classification of mixed exocrine-endocrine neoplasms. Virchows Arch 2006;449:499-506.
12. Lantuejoul S, Soria JC, Moro-Sibilot D, Morat L, Veyrenc S, Lorimier P et al. Differential expression of telomerase reverse transcriptase (hTERT) in lung tumors. Br J Cancer 2004;90:1222-9.
13. Lantuejoul S, Moro D, Michalides RJ, Brambilla C, Brambilla E. Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors. Am J Surg Pathol 1998;22:1267-76.
14. Filosso PL, Rena O, Donati G, Casadio C, Ruffini E, Papalia E et al. Bronchial carcinoid tumors: surgical management and long-term outcome. J Thorac Cardiovasc Surg 2002;123:303-9.
15. Cardillo G, Sera F, Di Martino M, Graziano P, Giunti R, Carbone L et al. Bronchial carcinoid tumors: nodal status and long-term survival after resection. Ann Thorac Surg 2004;77:1781-5.
16. Ferolla P, Daddi N, Urbani M, Semeraro A, Ribacchi R, Giovenali P. Tumorlets, multicentric carcinoids, lymph-nodal metastases, and longterm behavior in bronchial carcinoids. J Thorac Oncol 2009;4:383-7.
17. Naalsund A, Rostad H, Strom EH, Lund MB, Strand TE. Carcinoid lung tumors-incidence, treatment and outcomes: a population-based study. Eur J Cardiothorac Surg 2011;39:565-9.
18. Fernandez FG, Battafarano RJ. Large-cell neuroendocrine carcinoma of the lung. Cancer Control 2006;13:270-5.
19. Veronesi G, Morandi U, Alloisio M, Terzi A, Cardillo G, Filosso P et al. Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases. Lung Cancer 2006;53:111-5.
20. Detterbeck FC. Management of carcinoid tumors. Ann Thorac Surg 2010; 89:998-1005.
21. Rossi G, Cavazza A, Marchioni A, Longo L, Migaldi M, Sartori G et al. Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung. J Clin Oncol 2005;23:8774-85.
22. Rossi G, Mengoli MC, Cavazza A. Pulmonary large cell neuroendocrine carcinoma: a true high-grade neuroendocrine tumor needing prospective therapeutic data. J Thorac Oncol 2011;6:1775.